Aug. 17 at 2:42 PM
$LFMD LifeMD got screwed by Novo despite them playing by the book. The profit difference between compounded and branded is massive and LifeMD switched soon as they were supposed to, which not only lost them on pricing competitiveness, they also took over a year to recover. If LifeMD simply continued the same way HIMS did, they would be doing far better financially. It's not really management being incompetent, it's because management decided to play it straight, that they are struggling but as you can see, even HIMS is losing money now that they switched to branded. Q4 ER will be the biggest one for them and according to them, when they will finally turn this around.